Drug FDA Class II Ongoing Foreign material
Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJOF, LLC, Ledgewood, NJ 07852, NDC 71384-512-0.1
Imprimis NJOF, LLC Published Jan 14, 2026
Risk level
Class IIMay cause a temporary or reversible health problem; slight chance of serious harm.
Severity score 60/100
What should you do?
- Check whether you have this product, using the lot codes, UPCs, and dates listed below.
- Do not eat, serve, or sell the affected product.
- Return it to the place of purchase for a refund, or throw it away in a sealed bag so people and animals can’t get to it.
- Contact Imprimis NJOF, LLC or your place of purchase with questions, and see the source record below for full details.
Reason for recall
Presence of particulate matter - Glass like particles.
Hazards
Glass Particulate · primary
Affected products (1)
Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJOF, LLC, Ledgewood, NJ 07852, NDC 71384-512-0.1
778 boxes of 15,540 pre-filled syringes
Lot codes: 25MAY051
Code info: Lot: 25MAY051, Expires: 06/26/2026; 25AUG003, Expires:08/07/2026
Affected areas
Nationwide
Timeline
- InitiatedDec 18, 2025
- PublishedJan 14, 2026
- Recall number
- D-0249-2026
- Agency
- U.S. Food and Drug Administration
- Country
- US
FDA records come from the openFDA drug enforcement-report dataset — the agency's full weekly enforcement list. Most entries are not issued as consumer press releases, so they won't appear on fda.gov/recalls or in a web search. The source record link above resolves this exact recall by its number.